BETA Technologies Completes First FAA eVTOL Flights, Stock Rises 5%
BETA Technologies Inc (NYSE:BETA) reported that its shares increased by approximately 5.1% on Friday following the completion of its first electric aircraft flights conducted under the Federal Aviation Administration’s eVTOL Integration Pilot Program (eIPP). The flights, which carried manufactured organ products being developed by United Therapeutics Corporation (NASDAQ:UTHR), represent the initial use case in a series that will eventually span at least 26 states nationwide.
The inaugural campaign demonstrated operations across a multistate corridor linking Virginia Tech/Montgomery Executive Airport in Blacksburg, Virginia; Charlottesville‑Albemarle Airport in Charlottesville, Virginia; Frederick Municipal Airport in Frederick, Maryland; and Martin State Airport in Baltimore County, Maryland. The missions covered roughly 275 nautical miles.
BETA was selected to participate in seven of the FAA’s eight eIPP launch programs, the highest number of any electric aircraft developer. The company maintains a partnership with United Therapeutics to develop and operate electric aircraft for the future commercial delivery of organ products.
The eVTOL Integration Pilot Program was created by the U.S. Department of Transportation and the FAA to accelerate the safe integration of Advanced Air Mobility (AAM) through operational demonstrations, with the aim of informing future certification policy, operational frameworks, and broader commercialization of AAM across the United States.
To date, BETA has accumulated more than 160,000 nautical miles of flight experience and has established charging infrastructure at 123 sites throughout the United States and Canada. The company manufactures both conventional fixed‑wing electric aircraft and electric vertical take‑off and landing (eVTOL) aircraft.